These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15497763)

  • 41. Omeprazole and talampanel as two examples of retrometabolic drug design.
    Andrási F; Berzsenyi P; Farkas L; Körösi J; Hámori T; Botka P; Ling I; Láng T
    Pharmazie; 2004 May; 59(5):365-6. PubMed ID: 15212302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Inhibition of serum cholinesterase by means of the plastic serum filter Seraclear].
    Bauer K; Gabl F
    Med Lab (Stuttg); 1979 Jul; 32(7):170-2. PubMed ID: 470804
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the determination of serum cholinesterase by the "paper reagent" method].
    VINCENT D; SEGONZAC G; MARQUES-VINCENT MC
    Ann Biol Clin (Paris); 1963; 21():481-90. PubMed ID: 13997333
    [No Abstract]   [Full Text] [Related]  

  • 44. [Estimation of the activity of cholinesterase in fresh serum (clinical use of akoresuto)].
    KUBONOYA J; FUJITA K; KIMURA S; IWAO Y; HISA S
    Rinsho Byori; 1962 Dec; 10():687-90. PubMed ID: 13927256
    [No Abstract]   [Full Text] [Related]  

  • 45. Esophageal aperistalsis and achalasia produced in dogs by prolonged cholinesterase inhibition.
    HARRIS LD; ASHWORTH WD; INGELFINGER FJ
    J Clin Invest; 1960 Nov; 39(11):1744-51. PubMed ID: 13711752
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prolongation of the curarizing activity of succinylcholine by means of some cholinesterase antagonists].
    MAROTTA M
    Boll Soc Ital Biol Sper; 1953 Apr; 29(4):585-8. PubMed ID: 13105963
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of cholinesterase inhibitors on lipolytic activity of the aorta in rats].
    PATELSKI J; SZWEDZIKOWSKI S
    Acta Physiol Pol; 1960; 11():858-9. PubMed ID: 13733279
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of electrophoresis on eserine inhibition of blood cholinesterase].
    VINCENT D; SEGONZAC G
    C R Seances Soc Biol Fil; 1957; 151(4):787-90. PubMed ID: 13489983
    [No Abstract]   [Full Text] [Related]  

  • 49. [Problem of cholinesterase-inhibiting effect of Polymethylene-dicarbamic acid-bis-choline ester].
    STUMPF C; HERZFELD E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 225(1-2):119-21. PubMed ID: 14394175
    [No Abstract]   [Full Text] [Related]  

  • 50. A review of the status of omeprazole: the Hambury workshop.
    Hunt R; Sachs G
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):1S-2S. PubMed ID: 7859581
    [No Abstract]   [Full Text] [Related]  

  • 51. The mechanism of the irreversible inhibition of cholinesterase by the alkyl phosphate esters.
    MYERS DK
    Acta Physiol Pharmacol Neerl; 1953; 3(1):136-8. PubMed ID: 13123970
    [No Abstract]   [Full Text] [Related]  

  • 52. [Influence of the inhibition of cerebral cholinesterase on duration of narcosis].
    HOLTZ P; BALZER H; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 233(5):438-67. PubMed ID: 13552773
    [No Abstract]   [Full Text] [Related]  

  • 53. The mechanism of action of anti-cholinesterases.
    COHEN JA; POSTHUMUS CH
    Acta Physiol Pharmacol Neerl; 1955; 4(1):17-36. PubMed ID: 14387734
    [No Abstract]   [Full Text] [Related]  

  • 54. Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet.
    Sodhi RK; Singh N
    PLoS One; 2013; 8(7):e70487. PubMed ID: 23936214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum cholinesterase inhibition by omeprazole and lansoprazole.
    Mequid S; Ramzan I
    Pharmazie; 2004 Sep; 59(9):733. PubMed ID: 15497763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.
    Naseri E; Yenisehirli A
    Eur J Pharmacol; 2006 Feb; 531(1-3):226-31. PubMed ID: 16438963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro.
    Aydin C; Sarac B; Koyuncu A; Yildirim S; Sen M; Sarioglu Y
    J Gastroenterol; 2003; 38(8):765-71. PubMed ID: 14505131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of lansoprazole on human leukocyte function.
    Capodicasa E; De Bellis F; Pelli MA
    Immunopharmacol Immunotoxicol; 1999 May; 21(2):357-77. PubMed ID: 10319286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium.
    Yenisehirli A; Onur R
    Eur J Pharmacol; 2005 Sep; 519(3):259-66. PubMed ID: 16125697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review article: similarities and differences among delayed-release proton-pump inhibitor formulations.
    Horn JR; Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():20-4. PubMed ID: 16303033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.